ARCHIVES

In Brief: Pursell Most Likely To Replace Conte, Foriend Of Cancer Program; DeVita Names Associate

This article is from The Cancer Letter archive.

Vol. 17 No. 07 | February 15, 1991

Download PDF Visit The Full Archive

Related Articles

Funding and Direction of IL-2/LAK Trials Questioned By DCT Board

March 3, 1989

ECOG Subcontractors Critique Cancer Control Program

August 24, 1979

Phase III Study: Rituxan Improved PFS By 79% In Advanced Follicular Lymphoma

December 31, 2010

Bush Asks Hammer To Probe FDA Regulation Of Anticancer Drugs

June 17, 1988

Examples Of CCOP Cancer Control Projects Listed

May 16, 1986

Tivozanib Does Not Improve OS Compared to Sorafenib

February 22, 2013